myra solano garcia, diagnosed with alzheimer's, credits the drug kisunla for slowing her mental decline. Although there's no cure, she participates in a clinical trial and actively engages in her community.

A 66-year-old woman diagnosed with alzheimer's who began taking the drug donanemab.

The drug approved by the FDA that may slow the decline of alzheimer's.

Another drug approved to treat alzheimer's alongside kisunla.

University of Southern California, where Myra participated in the clinical trial.

Professor at usc overseeing the donanemab trial.